Case of the Season: 177Lu-DOTATATE Peptide Receptor Radiotherapy With Acute Dialysis Support in a Patient With Chronic Kidney Disease (CKD)
{{output}}
Lutetium-177 DOTATATE is used in the treatment of somatostatin-expressing neuroendocrine tumors and is termed peptide receptor radiotherapy (PRRT). The radionuclide agent is injected intravenously, binds to the somatostatin receptors (type 2) on the surface of... ...
